Correlation Between Sex and Prognosis of Acute Aortic Dissection in the Chinese Population
Overview
- Phase
- Not Applicable
- Intervention
- Surgery
- Conditions
- Acute Aortic Dissection
- Sponsor
- Shenyang Northern Hospital
- Enrollment
- 884
- Primary Endpoint
- The outcome measure describes aortic disease-related death，aortic dissection, paraplegia, myocardial ischemia, renal insufficiency and other aortic complications.
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
The study evaluated the prevalence, presentation, management, and prognosis of coronary heart disease differ according to sex.
Detailed Description
The study included 884 patients enrolled in our institute between June 2002 and May 2016. Considering psychosocial factors, treatments, and the outcomes in men versus those in women with acute aortic dissection, explored the association of sex with psychosocial characteristics and mortality risk. Of 884 patients, 211 (23.9%) were women. The median duration of follow-up was 2.9 years (25th -75th percentiles: 1-4 years ).
Investigators
Han Yaling, MD
Correlation between sex and prognosis of acute aortic dissection in the Chinese population
Shenyang Northern Hospital
Eligibility Criteria
Inclusion Criteria
- •acute aortic dissection
Exclusion Criteria
- •Chronic aortic dissection
Arms & Interventions
female
Drug:Beta-blocker,Angiotensin II receptor blocker,Angiotensin-converting enzyme,Calcium-channel blocker,Aspirin,Statin
Intervention: Surgery
male
Drug:Beta-blocker,Angiotensin II receptor blocker,Angiotensin-converting enzyme,Calcium-channel blocker,Aspirin,Statin
Intervention: drug
male
Drug:Beta-blocker,Angiotensin II receptor blocker,Angiotensin-converting enzyme,Calcium-channel blocker,Aspirin,Statin
Intervention: Surgery
female
Drug:Beta-blocker,Angiotensin II receptor blocker,Angiotensin-converting enzyme,Calcium-channel blocker,Aspirin,Statin
Intervention: drug
Outcomes
Primary Outcomes
The outcome measure describes aortic disease-related death，aortic dissection, paraplegia, myocardial ischemia, renal insufficiency and other aortic complications.
Time Frame: 2.9years
The study's primary endpoint during the follow up was the composite of aortic disease-related death, aortic dissection, paraplegia, myocardial ischemia, renal insufficiency and other aortic complications during follow-up.